Back

Association of third-trimester N-terminal pro-brain natriuretic peptide levels and pre-eclampsia development

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in pregnancy and childhood Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Lucas Bacmeister

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

8 More presentations in this session

Presentation thumbnail
Severity of pulmonary hypertension and pregnancy outcomes: newer insights from the M-PAC registry
Professor J. Gnanaraj (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Association of adverse childhood experiences with adult-onset cardiometabolic conditions and prescription medicine use
Doctor S. Caglayan (Tromso, NO)
Abstract Slides Video
Presentation thumbnail
Ultrasound-guided versus palpation-guided techniques for vessel catheterization in children undergoing cardiac surgery. A systematic review and meta-analysis of randomized controlled trials.
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes in pregnant women with congenital heart disease
Doctor S. Kanigalpula (Kansas City, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular (reverse) remodelling induced by pregnancy: looking at the right side of the heart
Miss A. Ferreira (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in pregnancy and childhood

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.
thumbnail
Congress Presentation
Role of urinary 11-dehydro-thromboxane B2 as a predictor of preeclampsia in pregnant high-risk women on low-dose aspirin treatment
thumbnail
Congress Presentation
Enhancing primary prevention: the incremental predictive value of NTproBNP beyond ASCVD risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources